
Opinion|Videos|March 27, 2025
Optimizing ADC Supportive Care Prescribing and AE Management With Institutional Workflows
Panelists discuss how health care professionals use standardized antibody-drug conjugate (ADC) pathways to guide dosing, adverse effect (AE) management, and transitions. Protocols ensure monitoring, toxicity mitigation, and seamless shifts between therapies for optimal care.
Advertisement
Video content above has been prompted by the following:
- How does your institution incorporate treatment pathways or workflows to guide decision-making, dosing, AE management/monitoring, and patient transitions between different ADCs?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Rapid CAR T Expansion Linked to Delayed Neurotoxicity in Patients Treated With Cilta-Cel
2
Hercessi, Biosimilar to Herceptin, Shows Favorable Efficacy, Safety in Treating HER2+ MBC in Real-World Setting
3
IMS: Shaping the Future of Multiple Myeloma with Anti-CD38 Quadruplets
4
Nirmatrelvir-Ritonavir Has Variable Impact on Incidence of Post-COVID-19 Condition
5